Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
144.33B
Market cap144.33B
Price-Earnings ratio
14.61
Price-Earnings ratio14.61
Dividend yield
6.82%
Dividend yield6.82%
Average volume
126.04M
Average volume126.04M
High today
$25.57
High today$25.57
Low today
$24.96
Low today$24.96
Open price
$25.10
Open price$25.10
Volume
38.30M
Volume38.30M
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

As of today, Pfizer(PFE) shares are valued at $25.39. The company's market cap stands at 144.33B, with a P/E ratio of 14.61 and a dividend yield of 6.8%.

On 2025-11-17, Pfizer(PFE) stock moved within a range of $24.96 to $25.57. With shares now at $25.39, the stock is trading +1.7% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 38.3M, compared to an average daily volume of 126.04M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

PFE News

The Motley Fool 8h
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?

Healthcare stocks have far outperformed the broader market over the past month. The healthcare sector has been on fire in recent weeks. The S&P 500 Healthcare...

This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000?
Nasdaq 9h
Down 55%, Should You Buy the Dip on Pfizer?

Key Points Pfizer is a $145 billion pharmaceutical industry giant with a long history of success behind it. Wall Street bid the stock up during the COVID-19 p...

Down 55%, Should You Buy the Dip on Pfizer?
Nasdaq 2d
Is Pfizer Stock a Buy After This $10 Billion Acquisition?

Key Points Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading candidate could be an e...

Is Pfizer Stock a Buy After This $10 Billion Acquisition?

Analyst ratings

56%

of 27 ratings
Buy
40.7%
Hold
55.6%
Sell
3.7%

More PFE News

Simply Wall St 2d
A Fresh Look at Pfizer’s Valuation as Share Price Shows Signs of Recovery

Pfizer (PFE) has been a topic of interest for investors, especially as its stock returned nearly 3% over the past month. Despite some ups and downs this year, t...

A Fresh Look at Pfizer’s Valuation as Share Price Shows Signs of Recovery
TipRanks 3d
Starboard takes new stake in Bill Holdings, exits Pfizer position

Jeffrey Smith’s Starboard Value disclosed in an SEC filing its holdings as of September 30, 2025. Starboard’s one new buys during the third quarter was Bill Hol...

TipRanks 4d
Pfizer Completes Acquisition of Metsera for $7 Billion

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

TipRanks 4d
Pfizer Stock Rises as Metsera Shareholders Approve $10B Acquisition Offer

Pfizer’s shares (PFE) edged higher on Thursday after shareholders of Metsera (MTSR) approved the American pharma giant’s offer of up to $10 billion to take over...

TipRanks 4d
Pfizer completes acquisition of Metsera

Pfizer (PFE) announced the successful completion of its acquisition of Metsera (MTSR). “Pfizer has completed its acquisition of all outstanding shares of common...

Benzinga 4d
Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Pfizer (NYSE:PFE) is reportedly offloading its remaining stake in Covid-19 vaccine partner BioNTech SE (NASDAQ:BNTX) . BNTX is among today's weakest performers...

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run
TipRanks 4d
Mangoceuticals Stock Soars on Deal to Sell Obesity Drugs for Eli Lilly, Novo Nordisk

Shares of Mangoceuticals (MGRX), the Texas-based telehealth company focused on men’s health, rose sharply in early trading on Thursday, climbing 24.43% to $2.19...

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.